Wyeth Vaccines GM James Connolly: An Interview With “The Pink Sheet” DAILY

Exec outlines Wyeth’s aim to double sales of the Prevnar franchise in the next five years, pipeline opportunities and vaccine pricing.

More from Archive

More from Pink Sheet